The Intra-arterial Vasospasm Trial

PHASE4TerminatedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 29, 2016

Primary Completion Date

April 29, 2024

Study Completion Date

August 12, 2024

Conditions
Cerebral Vasospasm
Interventions
DRUG

Nicardipine

Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm

DRUG

Verapamil

Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm

DRUG

Nicardipine + Verapamil + Nitroglycerin

Pharmacological angioplasty: intra-arterial drug infusion via catheter to treat cerebral vasospasm

Trial Locations (5)

11030

Northwell Health, Manhasset

17822

Geisinger Clinic, Danville

27157

Wake Forest University Health Sciences, Winston-Salem

77030

University of Texas Medical School at Houston, Houston

06520

Yale School of Medicine, New Haven

Sponsors
All Listed Sponsors
collaborator

Yale University

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

Wake Forest University Health Sciences

OTHER

collaborator

Temple University

OTHER

collaborator

Geisinger Clinic

OTHER

collaborator

Northwell Health

OTHER

collaborator

University of Michigan

OTHER

collaborator

Lenox Hill Hospital

OTHER

collaborator

Weatherhead Foundation

UNKNOWN

collaborator

University of California, Irvine

OTHER

lead

Peng Roc Chen, MD

OTHER